projects:workgroups:clinicalstudy
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
projects:workgroups:clinicalstudy [2019/02/21 13:26] sdolley |
projects:workgroups:clinicalstudy [2019/03/01 18:21] sdolley |
||
|---|---|---|---|
| Line 5: | Line 5: | ||
| **Objective:** Understand clinical trial use cases where the OHDSI platform & ecosystem can aid trials in any aspect, and assist in driving updates in OHDSI tools to support. This might be to represent data from interventional trial or observational study in OMOP CDM, might include enabling feasibility analysis, might include trial data collection, supporting biostatistics, or delivering real-world evidence to help trialists, or other. | **Objective:** Understand clinical trial use cases where the OHDSI platform & ecosystem can aid trials in any aspect, and assist in driving updates in OHDSI tools to support. This might be to represent data from interventional trial or observational study in OMOP CDM, might include enabling feasibility analysis, might include trial data collection, supporting biostatistics, or delivering real-world evidence to help trialists, or other. | ||
| - | **Project Lead:** Shawn Dolley (ping on OHDSI forum or shawn@shawndolley.com) | + | **Project Lead:** Shawn Dolley, Gates Foundation (ping on OHDSI forum or shawn@shawndolley.com) |
| **Members:** | **Members:** | ||
| * Andrew Williams, PhD, Tufts | * Andrew Williams, PhD, Tufts | ||
| - | * Greg Klebanov, Odysseus | + | * Greg Klebanov, MS, Odysseus |
| * Rupa Makadia, PhD, Janssen | * Rupa Makadia, PhD, Janssen | ||
| * Vojtech Huser, PhD, NIH | * Vojtech Huser, PhD, NIH | ||
| Line 18: | Line 18: | ||
| * Ana Heredia, GMV | * Ana Heredia, GMV | ||
| * Ayesha Kang, Deloitte | * Ayesha Kang, Deloitte | ||
| - | * Kees van Bochove, The Hyve | + | * Kees van Bochove, MS, The Hyve |
| - | * Maxim Moinat, The Hyve | + | * Maxim Moinat, MS, The Hyve |
| + | * Sonia Araujo, PhD, IQVIA | ||
| **Start Date:** 2019 (this started as 'Clinical Study' working group in 2016 and was dormant) | **Start Date:** 2019 (this started as 'Clinical Study' working group in 2016 and was dormant) | ||
| - | **Repository:** To be organized soon. | + | **Repository:** |
| + | White paper on RWE in trials: | ||
| + | * {{:projects:workgroups:using-real-world-evidence-to-optimize-clinical-trials_2018-shyftanalytics.pdf|Using RWE in Trials by SHYFT Analytics}} | ||
| + | * {{:projects:workgroups:SHYFT-OHDSI-POSTER.pdf|Poster: Leveraging the OMOP CDMv5 for CDISC SDTM RCT Data}} | ||
| </WRAP> | </WRAP> | ||
projects/workgroups/clinicalstudy.txt · Last modified: 2024/04/28 20:17 by zhen
Page Tools
